Login
Toggle navigation
Videos
Categories
Trending
Mr. CEO Unveils Embraer's New Turboprop with 250+ LOIs | Arjan Meijer - CEO of Embraer
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Arjan Meijer is Pres/CEO:Commercial Aviation at Embraer SA.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Expanding Horizons: Amy Lo on Asia’s Wealth Management Potential | Amy Lo – Chairman, Global Wealth Management Asia, UBS
00:10:00
"Transforming New York: Jeff Blau's Vision for Hudson Yards"
00:10:00
West African Gold Producer Focuses on Operational Excellence and Portfolio Diversification
00:10:00
Highcroft Mining: Advancing a World-Class Gold and Silver Project with Strategic Investments and Experienced Leadership
00:10:00
John Doerr on OKRs, Leadership, and the Future of Technology | John Doerr, Chairman, Kleiner Perkins.
00:10:00
AI researchers investing in AI deeptech and the future of work|Josh Albrecht,General Partner,Outset Capital
00:10:00
Revolutionizing Commercial Real Estate Investment Through Innovative Technology and Secure Bond Offerings | Falk Raudies , CEO, FCR Immobilien AG.
00:10:00
Analyzing Market Opportunities: Insights into the Foord Equity Fund | Cobie Legrange - Fundamental Analyst, Acsis
00:00:00
Chee-Chee H. Stucky, M.D. Endocrine Surgeon, Mayo Clinic / Is there a connection between breast cancer and pancreatic cancer
00:10:00
The Age of Reagan: Uniting Foreign Policy and Domestic Vision|Steven Hayward
00:10:00
Embracing the Future: A Journey Towards Innovation and Globalization in Brazilian Companies | Efraim Horn, CEO , Cyrela Brazil Realty SA Empreendimentos e Participacoes.
00:10:00
Hawkins Project Exploration Update: Key Findings and High-Grade Sampling Insights